| Overview |
| Development Programs |
| Management |
| Investor Information |
| Careers |
| Contact Us |
| U.S. Contact Information | |
| Address: | 750 Lexington Ave., 26th Floor |
| NY, NY 10022 | |
| U.S.A. | |
| Tel: | +1-212-531-5965 |
| Fax: | +1-212-531-5961 |
| E-mail: | ron@keryx.com |
| Israel Contact Information | |
| Address: | 7 Hartom St. |
| Har Hotzvim | |
| P.O. Box 23706 | |
| Jerusalem 91236 | |
| Israel | |
| Tel: | +972 2 541-3500 |
| Fax: | +972 2 541-3501 |
| E-mail: | ron@keryx.com |
Investor Relations Contacts
| Ron Bentsur | |
| Director of Investor Relations | |
| Keryx Biopharmaceuticals | |
| Tel: | +972 2 541 3500 |
| E-mail: | ron@keryx.com |
| Paul Holm | |
| Managing Director | |
| PortfolioPR Investor/Public Relations & Marketing Communications | |
| Tel: | +1 212 736 9224 |
| E-mail: | pholm@portfoliopr.com |
Copyright © 2002 by Keryx Biopharmaceuticals, Inc.
